Kymera Therapeutics, Inc. (KYMR)

Kymera Therapeutics Stock Forecast

Stock Price Forecast

The 23 analysts that cover Kymera Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $105.96, which forecasts a 31.87% increase in the stock price over the next year. The lowest target is $52 and the highest is $138.

Price Target: $105.96 (+31.87%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$52	$105.96	$116	$138
Change	-35.28%	+31.87%	+44.37%	+71.75%

Analyst Ratings

The average analyst rating for Kymera Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Sep '25	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26
Strong Buy	8	9	10	12	12	12
Buy	8	9	9	11	11	11
Hold	1	0	0	0	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	17	18	19	23	24	24

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jeet Mukherjee BTIG	BTIG	Strong Buy Reiterates $138	Strong Buy	Reiterates	$138	+71.75%	Feb 3, 2026
Etzer Darout Barclays	Barclays	Buy Maintains $119 → $133	Buy	Maintains	$119 → $133	+65.53%	Jan 28, 2026
Jeet Mukherjee BTIG	BTIG	Strong Buy Reiterates $138	Strong Buy	Reiterates	$138	+71.75%	Jan 15, 2026
Andy Chen Wolfe Research	Wolfe Research	Buy → Hold Downgrades n/a	Buy → Hold	Downgrades	n/a	n/a	Jan 6, 2026
Kalpit Patel B. Riley Securities	B. Riley Securities	Strong Buy Maintains $80 → $117	Strong Buy	Maintains	$80 → $117	+45.61%	Dec 22, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

55.88M

Increased by 18.71%

from 47.07M

Revenue Next Year

49.78M

Decreased by -10.91%

from 55.88M

EPS This Year

-3.54

from -2.98

EPS Next Year

-3.77

from -3.54

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	34.03M	72.83M	46.83M	78.59M	47.07M	55.88M	49.78M
Revenue Growth	1,059.99%	114.00%	-35.71%	67.84%	-40.11%	18.71%	-10.91%
EPS	-3.15	-2.09	-2.87	-2.52	-2.98	-3.54	-3.77
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	25	25

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029	2030
High	110.3M	105.0M
Avg	55.9M	49.8M
Low	38.2M	9.8M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029	2030
High	134.2%	87.9%
Avg	18.7%	-10.9%
Low	-18.8%	-82.5%

EPS Forecast

EPS	2025	2026	2027	2028	2029	2030
High	-2.91	-3.14
Avg	-3.54	-3.77
Low	-3.78	-5.89

EPS Growth

EPS Growth	2025	2026	2027	2028	2029	2030
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.